PRRT2 and cancer: Cytoplasmic PKC-θ is a feature of normal CD4+ and CD8+ T cells in healthy individuals, while mesenchymal cancer cell lines and CTCs isolated from patients resistant to immunotherapy show high nuclear bias of PKC-θ expression.